FAP and lung cancer: Interestingly nineteen patients underwent static and dynamic 68Ga-FAPI-46 PET in addition to FDG in order to characterise lepidic lung cancer as a known FDG–negative target, and FAP IHC of 24 tissue sections of lepidic lung cancer surprisingly revealed strong FAP positivity in all specimens.